USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$39.50 USD
+0.10 (0.25%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $39.46 -0.04 (-0.10%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth B Momentum A VGM
Brokerage Reports
0 items in cart
USANA Health Sciences, Inc. [USNA]
Reports for Purchase
Showing records 121 - 129 ( 129 total )
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Raising PT and Estimates on Solid Q3 Upside, but U.S. Still Sluggish and Upcoming China Challenges Loom
Provider: WEDBUSH SECURITIES INC.
Analyst: DIONISIO R
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
China Opportunity Presented to Global Sales Reps
Provider: WEDBUSH SECURITIES INC.
Analyst: DIONISIO R
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Acquisition to Gain Foothold in China, but Comes at an Expensive Multiple
Provider: WEDBUSH SECURITIES INC.
Analyst: DIONISIO R
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Q2 Upside Driven Largely by F/X Gains, but Core N. America Business Reverts Back to Negative Sales Comparisons
Provider: WEDBUSH SECURITIES INC.
Analyst: DIONISIO R
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Company: USANA Health Sciences, Inc.
Industry: Medical - Drugs
Impressive Q1 Upside, but 2010 Guidance Increase Less than Magnitude of Q1 Beat
Provider: WEDBUSH SECURITIES INC.
Analyst: DIONISIO R